Next-Generation IVD Market, By Product Type (Reagents & Consumables, Instruments & Analyzers, and Software & Data Analytics Platforms), By Technology, By Testing Mode, By Sample Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4041
|
Published Date
June 2025
|
Pages
383
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Next-Generation IVD Market size was valued at US$ 9,545.67 Million in 2024, expanding at a CAGR of 5.5% from 2025 to 2032.
The Next-Generation In Vitro Diagnostics (IVD) market encompasses cutting-edge diagnostic technologies that enable faster, more accurate, and comprehensive disease detection through innovations such as genomics, proteomics, and AI-driven analysis. The growing emphasis on personalized medicine and the need for early and precise diagnosis are key drivers of market expansion, as healthcare systems increasingly aim to reduce diagnostic errors and enhance patient outcomes. According to the National Institutes of Health (NIH), genetic testing has helped identify hereditary conditions in approximately 5% of the U.S. population, illustrating the transformative potential of advanced diagnostic tools. These technologies are being rapidly integrated into clinical workflows for areas such as oncology, infectious disease, and chronic condition management.
Despite their promise, the market faces challenges including high R&D and development costs, complex regulatory approval processes, and ongoing data privacy and interoperability concerns. However, significant government investments in digital health infrastructure, especially in the U.S., Europe, and Asia-Pacific, are creating new opportunities for innovation and market penetration. As next-generation diagnostics become more accessible and integrated into standard care, the market is poised for robust growth, driven by advancements in biomarker discovery, automation, and cloud-based diagnostic platforms.
Next-Generation IVD Market- Market Dynamics
Advancements in Precision Diagnostics to Drive Accelerated Adoption of Next-Generation IVD Solutions
Advancements in precision diagnostics are revolutionizing healthcare by enabling earlier, faster, and more accurate disease detection—critical for timely and effective treatment. According to the U.S. National Institutes of Health (NIH), nearly 70% of clinical decisions are now based on diagnostic test results, highlighting the pivotal role of next-generation in vitro diagnostics (IVD). Cutting-edge technologies such as high-throughput sequencing, advanced biomarker identification, and AI-assisted analysis are significantly enhancing personalized medicine, particularly in fields like oncology and infectious disease management. The U.S. Centers for Disease Control and Prevention (CDC) also stress the importance of rapid diagnostics in outbreak response, citing their ability to identify pathogens within hours instead of days. These innovations not only reduce diagnostic errors and healthcare costs but also improve access to testing in remote and underserved regions. As global healthcare systems shift toward precision, prevention, and efficiency, next-generation IVD solutions are becoming indispensable to modern medical practice.
Next-Generation IVD Market- Segmentation Analysis:
The Global Next-Generation IVD Market is segmented based on Product Type, Technology, Testing Mode, Sample Type, End User, and Region.
The in vitro diagnostics (IVD) market is segmented into three key product types: Reagents & Consumables, Instruments & Analyzers, and Software & Data Analytics Platforms. Reagents and consumables currently dominate the market due to their critical role in a wide range of diagnostic assays across infectious diseases, oncology, and genetic testing. These products are essential for routine lab operations and are consumed at high volumes, ensuring recurring demand. Instruments and analyzers provide advanced detection and automation capabilities, supporting precise and high-throughput diagnostics in both centralized and decentralized settings. Meanwhile, software and data analytics platforms represent the fastest-growing segment, as digital tools increasingly enable real-time data interpretation, result integration, and enhanced decision-making. According to a 2023 report by the U.S. Food and Drug Administration (FDA), more than 65% of newly approved IVD systems integrated AI-driven analytics, reflecting the growing emphasis on digital transformation in clinical diagnostics.
The market is further categorized into five technology segments: Molecular Diagnostics (including Next-Generation Sequencing [NGS] and Polymerase Chain Reaction [PCR]), Digital Pathology, Point-of-Care Testing (POCT), Biosensors & Lab-on-a-Chip, and Artificial Intelligence-Enabled Diagnostics. Molecular diagnostics leads the field, particularly with NGS and PCR technologies, due to their high sensitivity and specificity in genetic and infectious disease testing. Digital pathology is reshaping histopathological analysis by enabling remote tissue examination and computational pathology, which supports more efficient diagnosis and second opinions. Point-of-care testing offers rapid results at or near the patient site, improving clinical decision-making in urgent care and remote environments. Biosensors and lab-on-a-chip technologies bring portability and speed to diagnostics through miniaturized platforms, while AI-enabled diagnostics enhance accuracy and workflow efficiency by analyzing large datasets with minimal human intervention. The National Institutes of Health (NIH) reported in 2024 that federal funding for molecular diagnostics and AI-enabled tools increased by over 30% in response to growing demands for precision medicine and scalable diagnostic solutions.
Next-Generation IVD Market- Geographical Insights
The Next-Generation In Vitro Diagnostics (IVD) market demonstrates varied growth patterns across global regions, shaped by differences in healthcare infrastructure, investment levels, and technological readiness. North America leads the market, driven by advanced healthcare systems, widespread adoption of precision diagnostics, and strong government funding for innovation. The U.S., in particular, supports next-generation diagnostics through initiatives like the NIH’s All of Us Research Program, which promotes personalized medicine. Europe closely follows, bolstered by supportive regulatory frameworks and public-private research collaborations under programs such as Horizon Europe, which aim to advance precision healthcare across member states.
In the Asia-Pacific region, countries like China, Japan, and India are experiencing rapid market expansion due to increased healthcare spending, a rising burden of chronic and infectious diseases, and efforts to modernize diagnostic infrastructure. Meanwhile, Latin America and the Middle East & Africa are gradually integrating next-generation IVD technologies, supported by global health organizations and local government initiatives focused on improving diagnostic accessibility in underserved areas. Despite persistent infrastructure challenges, these regions are showing increasing demand for rapid, accurate, and affordable diagnostic solutions. Globally, governments are significantly investing in diagnostic innovation, with the World Health Organization (WHO), the U.S. Department of Health and Human Services (HHS), and the European Commission collectively allocating billions of dollars toward precision medicine, early disease detection, and pandemic preparedness. As a result, the global landscape reflects a growing emphasis on localized innovation and tailored deployment strategies to meet diverse regional healthcare needs.
Next-Generation IVD Market- Competitive Landscape:
The Next-Generation In Vitro Diagnostics (IVD) market is marked by intense competition among leading global players, driven by a strong focus on innovation and strategic collaborations. Companies are significantly investing in research and development to introduce advanced diagnostic tools that offer higher accuracy, faster turnaround times, and multiplexing capabilities. Collaborations with academic institutions and biotech firms are common, aiming to accelerate technology integration and streamline regulatory approvals. To capitalize on growing demand in emerging markets, key players are expanding their global presence through mergers, acquisitions, and joint ventures. In parallel, the integration of digital technologies—such as artificial intelligence and cloud-based analytics—is becoming a critical differentiator, enhancing diagnostic efficiency and personalized care. Regulatory compliance and the ability to swiftly adapt to evolving healthcare needs also shape the competitive landscape, pushing companies to maintain a technological edge while offering strong customer support and service.
Recent Developments:
- March 2022: Thermo Fisher Scientific launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform for clinical laboratories. It enables rapid and comprehensive genomic profiling within a single day, supporting precision medicine and improved patient management.
- September 2023: Fapon introduced the Shine i8000/9000 chemiluminescence immunoassay analyzers, offering ultra-high-throughput, modular diagnostic capabilities. These platforms support more than 10,000 tests daily, combining open-system flexibility with integrated reagents and raw materials to advance tailored diagnostics.
- November 2023: Roche launched the LightCycler PRO System, a next-generation quantitative PCR (qPCR) platform for both clinical and research applications. With enhanced precision, flexibility, and user-friendliness, the system supports over 200 research-use assays and 60 CE-IVD assays, furthering personalized healthcare and outbreak preparedness.
- January 2025: Revvity and Element Biosciences formed a partnership to deliver a next-generation sequencing-based IVD workflow for neonatal testing. This comprehensive solution is designed to improve newborn screening and rare disease detection, supporting both clinical diagnostics and genomic research on a global scale.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEXT-GENERATION IVD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Becton Dickinson
- BioMérieux
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Genomic Health (Exact Sciences)
- Hologic, Inc.
- Illumina, Inc.
- Invitae Corporation
- Myriad Genetics
- Natera, Inc.
- Qiagen
- Roche Diagnostics
- Sophia Genetics
- Thermo Fisher Scientific
- Others
GLOBAL NEXT-GENERATION IVD MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Reagents & Consumables
- Instruments & Analyzers
- Software & Data Analytics Platforms
GLOBAL NEXT-GENERATION IVD MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Molecular Diagnostics (NGS, PCR)
- Digital Pathology
- Point-of-Care Testing (POCT)
- Biosensors & Lab-on-a-Chip
- Artificial Intelligence-Enabled Diagnostics
GLOBAL NEXT-GENERATION IVD MARKET, BY TESTING MODE- MARKET ANALYSIS, 2019 - 2032
- Centralized Lab Testing
- Decentralized/POC Testing
- At-Home Testing
GLOBAL NEXT-GENERATION IVD MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032
- Blood
- Tissue/Biopsy
- Saliva
- Urine
- Other
GLOBAL NEXT-GENERATION IVD MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Infectious Diseases
- Genetic Testing
- Autoimmune Diseases
- Cardiovascular Diseases
- Pharmacogenomics
GLOBAL NEXT-GENERATION IVD MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Next-Generation IVD Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Next-Generation IVD Market Snippet by Product Type
2.1.2. Next-Generation IVD Market Snippet by Technology
2.1.3. Next-Generation IVD Market Snippet by Testing Mode
2.1.4. Next-Generation IVD Market Snippet by Sample Type
2.1.5. Next-Generation IVD Market Snippet by End User
2.1.6. Next-Generation IVD Market Snippet by Country
2.1.7. Next-Generation IVD Market Snippet by Region
2.2. Competitive Insights
3. Next-Generation IVD Key Market Trends
3.1. Next-Generation IVD Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Next-Generation IVD Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Next-Generation IVD Market Opportunities
3.4. Next-Generation IVD Market Future Trends
4. Next-Generation IVD Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Next-Generation IVD Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Next-Generation IVD Market Landscape
6.1. Next-Generation IVD Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Next-Generation IVD Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Reagents & Consumables
7.1.3. Instruments & Analyzers
7.1.4. Software & Data Analytics Platforms
8. Next-Generation IVD Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Molecular Diagnostics (NGS, PCR)
8.1.3. Digital Pathology
8.1.4. Point-of-Care Testing (POCT)
8.1.5. Biosensors & Lab-on-a-Chip
8.1.6. Artificial Intelligence-Enabled Diagnostics
9. Next-Generation IVD Market – By Testing Mode
9.1. Overview
9.1.1. Segment Share Analysis, By Testing Mode, 2024 & 2032 (%)
9.1.2. Centralized Lab Testing
9.1.3. Decentralized/POC Testing
9.1.4. At-Home Testing
10. Next-Generation IVD Market – By Sample Type
10.1. Overview
10.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
10.1.2. Blood
10.1.3. Tissue/Biopsy
10.1.4. Saliva
10.1.5. Urine
10.1.6. Other
11. Next-Generation IVD Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Oncology
11.1.3. Infectious Diseases
11.1.4. Genetic Testing
11.1.5. Autoimmune Diseases
11.1.6. Cardiovascular Diseases
11.1.7. Pharmacogenomics
12. Next-Generation IVD Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Next-Generation IVD Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Next-Generation IVD Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Next-Generation IVD Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Next-Generation IVD Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Next-Generation IVD Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Testing Mode, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Next-Generation IVD Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. Agilent Technologies
13.2.3. Becton Dickinson
13.2.4. BioMérieux
13.2.5. Danaher Corporation
13.2.6. F. Hoffmann-La Roche Ltd
13.2.7. Genomic Health (Exact Sciences)
13.2.8. Hologic, Inc.
13.2.9. Illumina, Inc.
13.2.10. Invitae Corporation
13.2.11. Myriad Genetics
13.2.12. Natera, Inc.
13.2.13. Qiagen
13.2.14. Roche Diagnostics
13.2.15. Sophia Genetics
13.2.16. Thermo Fisher Scientific
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
